Surrogacy Market
Surrogacy Market Forecasts to 2030 - Global Analysis By Type (Gestational Surrogacy, Traditional Surrogacy and Other Types), Age Group (Below 35 Years, 35-37 Years, 38-39 Years, 40-42 Years, 43-44 Years and Over 44 Years), Technology, End User and by Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $210.34 MN |
|
Projected Year Value (2030) |
US $362.82 MN |
|
CAGR (2023 - 2030) |
8.1% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Surrogacy Market is accounted for $210.34 million in 2023 and is expected to reach $362.82 million by 2030 growing at a CAGR of 8.1% during the forecast period. A surrogate woman bears and gives birth to a child on behalf of another person or couple in a reproductive arrangement known as surrogacy. When conventional conception is difficult or impossible due to medical conditions, this assisted reproductive technology is used. Moreover, the two main forms of surrogacy are gestational surrogacy, in which the surrogate carries an embryo fertilized by in vitro fertilization (IVF), usually using the genetic material of the intended parents or donors, and traditional surrogacy, in which the surrogate contributes her egg.
According to a report by the World Health Organization (WHO), one in four couples in developing nation’s experiences infertility. Additionally, 60–80 million couples worldwide suffer from infertility each year, with 15–20 million (25%) residing in India alone.
Market Dynamics:
Driver:
Raising awareness and acceptance
Growing awareness campaigns and a more candid conversation about fertility issues in society are supporting surrogacy's growing acceptance as a legal and compassionate reproductive option. Additionally, advocacy groups, internet forums, and educational programs help dispel the stigmas surrounding surrogacy and create a more encouraging atmosphere for single people and couples dealing with infertility.
Restraint:
Limited number of surrogates available
The surrogacy market is significantly constrained by the lack of willing and suitable surrogates. The process of matching intended parents with surrogates can be delayed when appropriate candidates who fulfill both medical and psychological requirements are difficult to find. Furthermore, social stigmas, worries about potential health hazards, or the rigorous requirements of the surrogacy procedure could all contribute to this shortage.
Opportunity:
Technological progress in reproductive health
Significant opportunities exist for the surrogacy market as a result of ongoing technological advancements in reproductive medicine, such as advances in genetic testing, embryo screening, and artificial reproductive techniques. Moreover, for intended parents, surrogacy is becoming a more practical and cost-effective option thanks to increased success rates, improved embryo selection, and the development of more advanced fertility treatments.
Threat:
Regulation changes and legal uncertainties
Diverse legal frameworks for surrogacy across different jurisdictions present a serious risk to the surrogacy industry. Additionally, swift alterations in laws or legal ambiguities could pose difficulties for surrogacy organizations, intended parents, and surrogates, resulting in possible legal conflicts and complications that could hinder the orderly advancement of surrogacy agreements.
Covid-19 Impact:
The COVID-19 pandemic has had a major effect on the surrogacy market and brought difficulties and disturbances to the assisted reproductive sector. Travel restrictions and lockdowns brought on by the pandemic have hindered the international mobility of intended parents, surrogates, and healthcare providers participating in the surrogacy process. There has been a brief decrease in surrogacy procedures due to ongoing health concerns, clinic closures, and delays in fertility treatments. Furthermore, the pandemic's effects on the economy could have an impact on intended parents' ability to afford surrogacy services.
The Gestational Surrogacy segment is expected to be the largest during the forecast period
As the most common and favored method of assisted reproduction, gestational surrogacy commands the largest share of the market. When a person is used in a gestational surrogacy, their eggs and sperm from donors or the intended parents are used to create an embryo through in vitro fertilization (IVF). This approach provides more emotional and legal clarity by severing genetic ties between the surrogate and the child. Moreover, reproductive technology advancements have made gestational surrogacy more widely recognized as a more controlled and predictable process.
The Fertility Clinics segment is expected to have the highest CAGR during the forecast period
In the surrogacy market, the segment with the highest CAGR is fertility clinics. These specialist clinics, which provide a range of cutting-edge reproductive services, are essential in tackling the growing incidence of infertility. Fertility clinics offer thorough diagnostic evaluations, state-of-the-art assisted reproductive technologies (ART), including in vitro fertilization (IVF), and individualized treatment programs made to meet each patient's or couple's specific needs. Additionally, the demand for the services provided by fertility clinics has increased due to rising societal acceptance of ART and increased awareness of fertility issues.
Region with largest share:
In the global surrogacy market, North America holds the largest share. Because of its sophisticated healthcare system, high level of awareness, and large investments in reproductive technologies, this region—which includes the United States and Canada—dominates. The high demand for fertility services is partly due to the cultural acceptance of assisted reproductive technologies (ART) and the prevalence of infertility problems. Moreover, North America's status as a major player in the reproductive healthcare industry is further cemented by the region's concentration of top fertility clinics, research institutes, and technological developments in the field.
Region with highest CAGR:
In terms of the global market for surrogacy, the Asia-Pacific region has the highest CAGR. The demand for reproductive services in Asia-Pacific is driven by the rising prevalence of infertility as well as increased understanding and acceptance of assisted reproductive technologies (ART). The region's rapid growth is caused by a number of factors, including evolving lifestyles, postponing family planning, and improvements in reproductive health. Furthermore, expanding fertility treatments and better healthcare infrastructure in Asia-Pacific nations support the market's growth.
Key players in the market
Some of the key players in Surrogacy market include Extraordinary Conceptions, Boston IVF, Growing Generations LLC, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Bourn Hall International, Houston Fertility Center, Circle Surrogacy & Egg Donation, Nova Ivi Fertility, Ovation Fertility, Scanfert Clinic and Care Fertility Group.
Key Developments:
In November 2023, IVI RMA, one of the largest reproductive medicine groups in the world, has signed a definitive agreement to acquire the North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO, from healthcare group Fresenius. The strategic additions will grow IVI RMA to become a leading fertility group in North America and reinforce the company’s commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.
In October 2023, Boston IVF, a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. This prestigious annual event, in New Orleans, Louisiana, from October 14-18, brought together global experts to share groundbreaking advancements in technology, treatments, and patient care in reproductive medicine.
Types Covered:
• Gestational Surrogacy
• Traditional Surrogacy
• Other Types
Age Groups Covered:
• Below 35 Years
• 35-37 Years
• 38-39 Years
• 40-42 Years
• 43-44 Years
• Over 44 Years
Technologies Covered:
• Intrauterine Insemination (IUI)
• In-vitro Fertilization (IVF)
• Other Technologies
End Users Covered:
• Hospitals
• Fertility Clinics
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Surrogacy Market, By Type
5.1 Introduction
5.2 Gestational Surrogacy
5.3 Traditional Surrogacy
5.4 Other Types
6 Global Surrogacy Market, By Age Group
6.1 Introduction
6.2 Below 35 Years
6.3 35-37 Years
6.4 38-39 Years
6.5 40-42 Years
6.6 43-44 Years
6.7 Over 44 Years
7 Global Surrogacy Market, By Technology
7.1 Introduction
7.2 Intrauterine Insemination (IUI)
7.3 In-vitro Fertilization (IVF)
7.3.1 Classical/Standard IVF
7.3.2 Intracytoplasmic Sperm Injection (ICSI)
7.4 Other Technologies
8 Global Surrogacy Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Fertility Clinics
8.4 Other End Users
9 Global Surrogacy Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Extraordinary Conceptions
11.2 Boston IVF
11.3 Growing Generations LLC
11.4 IVIRMA Global
11.5 Max Healthcare
11.6 New Hope Fertility Center
11.7 Bourn Hall International
11.8 Houston Fertility Center
11.9 Circle Surrogacy & Egg Donation
11.10 Nova Ivi Fertility
11.11 Ovation Fertility
11.12 Scanfert Clinic
11.13 Care Fertility Group
List of Tables
1 Global Surrogacy Market Outlook, By Region (2021-2030) ($MN)
2 Global Surrogacy Market Outlook, By Type (2021-2030) ($MN)
3 Global Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
4 Global Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
5 Global Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
6 Global Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
7 Global Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
8 Global Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
9 Global Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
10 Global Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
11 Global Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
12 Global Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
13 Global Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
14 Global Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
15 Global Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
16 Global Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
17 Global Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
18 Global Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
19 Global Surrogacy Market Outlook, By End User (2021-2030) ($MN)
20 Global Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
21 Global Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
22 Global Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
23 North America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
24 North America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
25 North America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
26 North America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
27 North America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
28 North America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
29 North America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
30 North America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
31 North America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
32 North America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
33 North America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
34 North America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
35 North America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
36 North America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
37 North America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
38 North America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
39 North America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
40 North America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
41 North America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
42 North America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
43 North America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
44 North America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
45 Europe Surrogacy Market Outlook, By Country (2021-2030) ($MN)
46 Europe Surrogacy Market Outlook, By Type (2021-2030) ($MN)
47 Europe Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
48 Europe Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
49 Europe Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
50 Europe Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
51 Europe Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
52 Europe Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
53 Europe Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
54 Europe Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
55 Europe Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
56 Europe Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
57 Europe Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
58 Europe Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
59 Europe Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
60 Europe Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
61 Europe Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
62 Europe Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
63 Europe Surrogacy Market Outlook, By End User (2021-2030) ($MN)
64 Europe Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
65 Europe Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
66 Europe Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
67 Asia Pacific Surrogacy Market Outlook, By Country (2021-2030) ($MN)
68 Asia Pacific Surrogacy Market Outlook, By Type (2021-2030) ($MN)
69 Asia Pacific Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
70 Asia Pacific Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
71 Asia Pacific Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
72 Asia Pacific Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
73 Asia Pacific Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
74 Asia Pacific Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
75 Asia Pacific Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
76 Asia Pacific Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
77 Asia Pacific Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
78 Asia Pacific Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
79 Asia Pacific Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
80 Asia Pacific Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
81 Asia Pacific Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
82 Asia Pacific Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
83 Asia Pacific Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
84 Asia Pacific Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
85 Asia Pacific Surrogacy Market Outlook, By End User (2021-2030) ($MN)
86 Asia Pacific Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
87 Asia Pacific Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
88 Asia Pacific Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
89 South America Surrogacy Market Outlook, By Country (2021-2030) ($MN)
90 South America Surrogacy Market Outlook, By Type (2021-2030) ($MN)
91 South America Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
92 South America Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
93 South America Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
94 South America Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
95 South America Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
96 South America Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
97 South America Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
98 South America Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
99 South America Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
100 South America Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
101 South America Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
102 South America Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
103 South America Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
104 South America Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
105 South America Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
106 South America Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
107 South America Surrogacy Market Outlook, By End User (2021-2030) ($MN)
108 South America Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
109 South America Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
110 South America Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
111 Middle East & Africa Surrogacy Market Outlook, By Country (2021-2030) ($MN)
112 Middle East & Africa Surrogacy Market Outlook, By Type (2021-2030) ($MN)
113 Middle East & Africa Surrogacy Market Outlook, By Gestational Surrogacy (2021-2030) ($MN)
114 Middle East & Africa Surrogacy Market Outlook, By Traditional Surrogacy (2021-2030) ($MN)
115 Middle East & Africa Surrogacy Market Outlook, By Other Types (2021-2030) ($MN)
116 Middle East & Africa Surrogacy Market Outlook, By Age Group (2021-2030) ($MN)
117 Middle East & Africa Surrogacy Market Outlook, By Below 35 Years (2021-2030) ($MN)
118 Middle East & Africa Surrogacy Market Outlook, By 35-37 Years (2021-2030) ($MN)
119 Middle East & Africa Surrogacy Market Outlook, By 38-39 Years (2021-2030) ($MN)
120 Middle East & Africa Surrogacy Market Outlook, By 40-42 Years (2021-2030) ($MN)
121 Middle East & Africa Surrogacy Market Outlook, By 43-44 Years (2021-2030) ($MN)
122 Middle East & Africa Surrogacy Market Outlook, By Over 44 Years (2021-2030) ($MN)
123 Middle East & Africa Surrogacy Market Outlook, By Technology (2021-2030) ($MN)
124 Middle East & Africa Surrogacy Market Outlook, By Intrauterine Insemination (IUI) (2021-2030) ($MN)
125 Middle East & Africa Surrogacy Market Outlook, By In-vitro Fertilization (IVF) (2021-2030) ($MN)
126 Middle East & Africa Surrogacy Market Outlook, By Classical/Standard IVF (2021-2030) ($MN)
127 Middle East & Africa Surrogacy Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2021-2030) ($MN)
128 Middle East & Africa Surrogacy Market Outlook, By Other Technologies (2021-2030) ($MN)
129 Middle East & Africa Surrogacy Market Outlook, By End User (2021-2030) ($MN)
130 Middle East & Africa Surrogacy Market Outlook, By Hospitals (2021-2030) ($MN)
131 Middle East & Africa Surrogacy Market Outlook, By Fertility Clinics (2021-2030) ($MN)
132 Middle East & Africa Surrogacy Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
